GSK said that IDRX-42 addresses all the key KIT mutations that drive tumour growth and progression in GIST, which is estimated to affect between 4,000 and 6,000 people in the US each year.
The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.
Approximately 80% of all GIST cases are driven by mutations in the KIT gene. The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely ...
The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of ...
Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...
Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
As the deputy editor who oversees Forbes Vetted’s beauty vertical, I rounded up the best teeth whitening kits based on recommendations from dentists and insights from five staff testers.
News Medical on MSN3d
Machine learning tool predicts cancer treatment response based on genetic mutationsA groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors ...
Meal kits and prepared meal delivery have changed weekday dinners for good. You don't have to run to the grocery store last minute or deal with the stress of figuring out what to make after a long ...
Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests ... Route of Entry for Semliki ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback